SCYNEXIS
SCYX
#10667
Rank
NZ$43.3 M
Marketcap
NZ$4.35
Share price
-8.64%
Change (1 day)
259.26%
Change (1 year)

EPS for SCYNEXIS (SCYX)

EPS in 2026 (TTM): NZ-$8.90

According to SCYNEXIS's latest financial reports the company's current EPS (TTM) is NZ-$9.51. In 2025 the company made an earnings per share (EPS) of NZ-$2.49 an increase over its 2024 EPS that were of NZ-$6.43.

EPS history for SCYNEXIS from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$8.90257.82%
2025NZ-$2.49-61.36%
2024NZ-$6.43-131.43%
2023NZ$20.47-195.24%
2022NZ-$21.5017.6%
2021NZ-$18.28-75.73%
2020NZ-$75.31-46.24%
2019NZ-$140.10242.14%
2018NZ-$40.95-70.21%
2017NZ-$137.47-40.51%
2016NZ-$231.06-41.04%
2015NZ-$391.92157.69%
2014NZ-$152.09-96.49%
2013NZ-$4,329307.85%
2012NZ-$1,061

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Galmed Pharmaceuticals
GLMD
NZ-$23.54 147.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Catalyst Pharmaceuticals
CPRX
NZ$3.31-134.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
NZ-$11.57 21.73%๐Ÿ‡บ๐Ÿ‡ธ USA
KemPharm
KMPH
NZ-$1.81-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA